Article ID Journal Published Year Pages File Type
2143542 Lung Cancer 2008 9 Pages PDF
Abstract
M/V seems to be a well-tolerated and effective chemotherapy regimen with low toxicity in patients with advanced NSCLC. It seems to be an interesting option even for patients ≥70 years or with a reduced performance status.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Preview
Efficacy and safety of combination chemotherapy with mitomycin and vinorelbine for the treatment of advanced non-small cell lung cancer
Authors
, , , , , ,